Specialty Pharmaceutical Business Investment Opportunities in Tustin

The startup is in the pre-revenue stage. - The business is not yet registered, and registration will be completed based on the investor’s choice and preferred country once funding is secured. - The founder is currently based in Tustin, California. - The founder has developed a pharmaceutical formula that stops the progression of vision loss caused by age-related macular degeneration (AMD) after years of research and development. - Worldwide, there are approximately 400 million AMD sufferers. - The medicine formula has been created, and the patent is currently in process. - For major markets, the company plans to partner with a well-positioned pharmaceutical manufacturer, preferably one with existing eye-care products, for distribution. - In less developed markets, distribution will be handled directly through professional networks and online sales programs, targeting patients and their physicians. - The promoter has experience in founding and growing medical device and ophthalmic companies. - He has led multiple mergers and acquisitions and developed innovative surgical and dental technologies, including intraocular lenses and fluidics-based devices. - He is also actively engaged in pioneering research on age-related macular degeneration and non-surgical aesthetic medical procedures.

The startup is in the pre-revenue stage. - The business is not yet registered, and registration will be completed based on the investor’s choice and preferred country once funding is secured. - The founder is currently based in Tustin, California. - The founder has developed a pharmaceutical formula that stops the progression of vision loss caused by age-related macular degeneration (AMD) after years of research and development. - Worldwide, there are approximately 400 million AMD sufferers. - The medicine formula has been created, and the patent is currently in process. - For major markets, the company plans to partner with a well-positioned pharmaceutical manufacturer, preferably one with existing eye-care products, for distribution. - In less developed markets, distribution will be handled directly through professional networks and online sales programs, targeting patients and their physicians. - The promoter has experience in founding and growing medical device and ophthalmic companies. - He has led multiple mergers and acquisitions and developed innovative surgical and dental technologies, including intraocular lenses and fluidics-based devices. - He is also actively engaged in pioneering research on age-related macular degeneration and non-surgical aesthetic medical procedures.